Neutrophil-targeted drug secures first FDA approval for inflammatory lung disease
Katie Kingwell
Topics & Concepts
Drug approvalMedicineDrugApproved drugPharmacologyDrug developmentDrug discoveryClinical researchIntensive care medicineBioinformaticsInternal medicineBiologyImmune responses and vaccinationsNeutrophil, Myeloperoxidase and Oxidative MechanismsTuberculosis Research and Epidemiology